Literature DB >> 3470268

Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy.

J J Weems, B J Davis, O C Tablan, L Kaufman, W J Martone.   

Abstract

Between November 1982 and July 1984, five patients at a 110-bed pediatric hospital were diagnosed with invasive filamentous fungal infection; three had invasive aspergillosis (IA) and two had invasive zygomycosis (IZ). All five had underlying hematologic malignancy (HM). In a case-control study, these five HM patients (cases) were compared to 10 autopsied HM patients without evidence of aspergillosis or zygomycosis (controls). Cases and controls did not differ in underlying disease or in the degree of immunosuppression, as measured by duration of granulocytopenia and number of platelet transfusions. However, case-patients were more likely than controls to have been hospitalized during the construction of a hospital addition (p less than 0.02, Fisher's exact test [FET]). Four (80%) of five HM patients autopsied during the period of construction had IA or IZ compared with one (5%) of 21 autopsied before construction began (p = 0.001, FET). These findings suggest that, in a population of comparably immunosuppressed patients, construction activity may represent an independent risk factor for IA or IZ. Hospitals caring for such patients should take precautions which minimize exposure of these patients to construction or renovation activity.

Entities:  

Mesh:

Year:  1987        PMID: 3470268     DOI: 10.1017/s0195941700067114

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  13 in total

1.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

2.  Invasive aspergillosis in neutropenic patients during hospital renovation: effectiveness of mechanical preventive measures in a prospective cohort of 438 patients.

Authors:  Michael Loschi; Caroline Thill; Christian Gray; Marion David; Marie-France Bagatha; Ali Chamseddine; Nathalie Contentin; Fabrice Jardin; Helene Lanic; Emilie Lemasle; Pascal Lenain; Aspasia Stamatoullas; Hervé Tilly; Stephane Lepretre
Journal:  Mycopathologia       Date:  2015-01-31       Impact factor: 2.574

3.  Molecular epidemiological study of Aspergillus fumigatus in a bone marrow transplantation unit by PCR amplification of ribosomal intergenic spacer sequences.

Authors:  S A Radford; E M Johnson; J P Leeming; M R Millar; J M Cornish; A B Foot; D W Warnock
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 4.  Fungal infections of the immunocompromised host: clinical and laboratory aspects.

Authors:  C E Musial; F R Cockerill; G D Roberts
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

5.  Epidemiology and Prevention of Invasive Aspergillosis.

Authors:  David W. Warnock; Rana A. Hajjeh; Brent A. Lasker
Journal:  Curr Infect Dis Rep       Date:  2001-12       Impact factor: 3.725

6.  Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies.

Authors:  G Todeschini; C Murari; R Bonesi; G Pizzolo; G Amaddi; A Ambrosetti; S Cerù; I Piacentini; N Martini; P Montresor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

Review 7.  Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment.

Authors:  T J Walsh; D M Dixon
Journal:  Eur J Epidemiol       Date:  1989-06       Impact factor: 8.082

8.  Temporofacial zygomycosis in a pregnant woman.

Authors:  M R Buhl; T P Joseph; B E Snelling; L Buhl
Journal:  Infection       Date:  1992 Jul-Aug       Impact factor: 3.553

Review 9.  Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients.

Authors:  Kimberly Partridge-Hinckley; Gale M Liddell; Nikolaos G Almyroudis; Brahm H Segal
Journal:  Mycopathologia       Date:  2009-12       Impact factor: 2.574

Review 10.  Hospital infection control in hematopoietic stem cell transplant recipients.

Authors:  C A Dykewicz
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.